Metrion Biosciences, a specialist ion channel contract research organization (CRO) and drug discovery company, and AMRI, a global contract research, development and manufacturing organization, have signed a new collaboration agreement. The alliance will promote Metrion’s electrophysiology and ion channel screening expertise to global pharmaceutical and biotechnology clients. AMRI will be able to offer its customers access to Metrion’s broad portfolio of assay tools and technologie...